nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—CYP1A1—head and neck cancer	0.658	1	CbGaD
Prazosin—SLC22A2—Vinblastine—head and neck cancer	0.0935	0.346	CbGbCtD
Prazosin—ABCG2—Fluorouracil—head and neck cancer	0.0745	0.276	CbGbCtD
Prazosin—ABCG2—Docetaxel—head and neck cancer	0.0569	0.21	CbGbCtD
Prazosin—ABCB1—Vinblastine—head and neck cancer	0.0249	0.0921	CbGbCtD
Prazosin—ABCB1—Docetaxel—head and neck cancer	0.0205	0.0759	CbGbCtD
Prazosin—HTR1D—trigeminal nerve—head and neck cancer	0.0039	0.137	CbGeAlD
Prazosin—HTR1D—cranial nerve—head and neck cancer	0.00278	0.0973	CbGeAlD
Prazosin—ORM1—saliva—head and neck cancer	0.00273	0.0954	CbGeAlD
Prazosin—SLC22A3—tongue—head and neck cancer	0.00134	0.047	CbGeAlD
Prazosin—MT3—head—head and neck cancer	0.00114	0.0401	CbGeAlD
Prazosin—KCNH7—head—head and neck cancer	0.00114	0.0401	CbGeAlD
Prazosin—SLC22A3—mouth—head and neck cancer	0.000902	0.0316	CbGeAlD
Prazosin—KCNH6—head—head and neck cancer	0.000816	0.0286	CbGeAlD
Prazosin—MT3—lymph node—head and neck cancer	0.000801	0.0281	CbGeAlD
Prazosin—ADRA1D—epithelium—head and neck cancer	0.000728	0.0255	CbGeAlD
Prazosin—SLC22A3—parotid gland—head and neck cancer	0.000628	0.022	CbGeAlD
Prazosin—SLC22A3—saliva-secreting gland—head and neck cancer	0.000602	0.0211	CbGeAlD
Prazosin—Angina pectoris—Vinblastine—head and neck cancer	0.000598	0.0264	CcSEcCtD
Prazosin—CYP1A1—mouth—head and neck cancer	0.000586	0.0205	CbGeAlD
Prazosin—HTR1D—connective tissue—head and neck cancer	0.000573	0.0201	CbGeAlD
Prazosin—SLC22A3—connective tissue—head and neck cancer	0.000553	0.0194	CbGeAlD
Prazosin—Pancreatitis—Hydroxyurea—head and neck cancer	0.000549	0.0242	CcSEcCtD
Prazosin—Drowsiness—Hydroxyurea—head and neck cancer	0.0005	0.022	CcSEcCtD
Prazosin—ADRA1B—head—head and neck cancer	0.000462	0.0162	CbGeAlD
Prazosin—ADRA1D—head—head and neck cancer	0.000452	0.0158	CbGeAlD
Prazosin—Hallucination—Hydroxyurea—head and neck cancer	0.000446	0.0197	CcSEcCtD
Prazosin—Alopecia—Vinblastine—head and neck cancer	0.000435	0.0191	CcSEcCtD
Prazosin—ABCG2—parotid gland—head and neck cancer	0.00043	0.0151	CbGeAlD
Prazosin—ADRA1A—epithelium—head and neck cancer	0.000418	0.0146	CbGeAlD
Prazosin—ABCG2—saliva-secreting gland—head and neck cancer	0.000412	0.0144	CbGeAlD
Prazosin—CYP1A1—parotid gland—head and neck cancer	0.000408	0.0143	CbGeAlD
Prazosin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000397	0.0175	CcSEcCtD
Prazosin—Alopecia—Hydroxyurea—head and neck cancer	0.000396	0.0175	CcSEcCtD
Prazosin—Angina pectoris—Fluorouracil—head and neck cancer	0.000393	0.0173	CcSEcCtD
Prazosin—Malaise—Vinblastine—head and neck cancer	0.000386	0.017	CcSEcCtD
Prazosin—Vertigo—Vinblastine—head and neck cancer	0.000385	0.0169	CcSEcCtD
Prazosin—SLC22A3—thyroid gland—head and neck cancer	0.000367	0.0129	CbGeAlD
Prazosin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000362	0.016	CcSEcCtD
Prazosin—Discomfort—Vinblastine—head and neck cancer	0.00036	0.0159	CcSEcCtD
Prazosin—Malaise—Hydroxyurea—head and neck cancer	0.000352	0.0155	CcSEcCtD
Prazosin—CYP1A1—epithelium—head and neck cancer	0.000341	0.0119	CbGeAlD
Prazosin—SLC22A1—head—head and neck cancer	0.000341	0.0119	CbGeAlD
Prazosin—Epistaxis—Fluorouracil—head and neck cancer	0.000339	0.0149	CcSEcCtD
Prazosin—HTR1D—head—head and neck cancer	0.000338	0.0118	CbGeAlD
Prazosin—ADRA2A—connective tissue—head and neck cancer	0.000335	0.0117	CbGeAlD
Prazosin—Discomfort—Hydroxyurea—head and neck cancer	0.000328	0.0145	CcSEcCtD
Prazosin—SLC22A3—head—head and neck cancer	0.000326	0.0114	CbGeAlD
Prazosin—ADRA1A—lymphoid tissue—head and neck cancer	0.000322	0.0113	CbGeAlD
Prazosin—Oedema—Hydroxyurea—head and neck cancer	0.000319	0.014	CcSEcCtD
Prazosin—Paraesthesia—Vinblastine—head and neck cancer	0.000314	0.0138	CcSEcCtD
Prazosin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000308	0.0136	CcSEcCtD
Prazosin—CYP1A1—trachea—head and neck cancer	0.000302	0.0106	CbGeAlD
Prazosin—Constipation—Vinblastine—head and neck cancer	0.000299	0.0132	CcSEcCtD
Prazosin—Pain—Vinblastine—head and neck cancer	0.000299	0.0132	CcSEcCtD
Prazosin—Feeling abnormal—Vinblastine—head and neck cancer	0.000288	0.0127	CcSEcCtD
Prazosin—Alopecia—Fluorouracil—head and neck cancer	0.000285	0.0126	CcSEcCtD
Prazosin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000284	0.0125	CcSEcCtD
Prazosin—Angina pectoris—Docetaxel—head and neck cancer	0.000284	0.0125	CcSEcCtD
Prazosin—Somnolence—Hydroxyurea—head and neck cancer	0.000283	0.0125	CcSEcCtD
Prazosin—HTR1A—head—head and neck cancer	0.000281	0.00986	CbGeAlD
Prazosin—ADRA2A—trachea—head and neck cancer	0.000281	0.00985	CbGeAlD
Prazosin—Fatigue—Hydroxyurea—head and neck cancer	0.000275	0.0121	CcSEcCtD
Prazosin—Constipation—Hydroxyurea—head and neck cancer	0.000272	0.012	CcSEcCtD
Prazosin—Pain—Hydroxyurea—head and neck cancer	0.000272	0.012	CcSEcCtD
Prazosin—Vision blurred—Fluorouracil—head and neck cancer	0.000265	0.0117	CcSEcCtD
Prazosin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000263	0.0116	CcSEcCtD
Prazosin—ORM1—lymph node—head and neck cancer	0.000261	0.00912	CbGeAlD
Prazosin—ADRA1A—head—head and neck cancer	0.000259	0.00909	CbGeAlD
Prazosin—Hypersensitivity—Vinblastine—head and neck cancer	0.000257	0.0113	CcSEcCtD
Prazosin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000252	0.0111	CcSEcCtD
Prazosin—ABCG2—thyroid gland—head and neck cancer	0.000251	0.0088	CbGeAlD
Prazosin—Asthenia—Vinblastine—head and neck cancer	0.000251	0.011	CcSEcCtD
Prazosin—KCNH2—head—head and neck cancer	0.000251	0.00878	CbGeAlD
Prazosin—Epistaxis—Docetaxel—head and neck cancer	0.000245	0.0108	CcSEcCtD
Prazosin—Diarrhoea—Vinblastine—head and neck cancer	0.000239	0.0105	CcSEcCtD
Prazosin—CYP1A1—thyroid gland—head and neck cancer	0.000239	0.00836	CbGeAlD
Prazosin—Discomfort—Fluorouracil—head and neck cancer	0.000236	0.0104	CcSEcCtD
Prazosin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000235	0.0103	CcSEcCtD
Prazosin—Dizziness—Vinblastine—head and neck cancer	0.000231	0.0102	CcSEcCtD
Prazosin—Oedema—Fluorouracil—head and neck cancer	0.000229	0.0101	CcSEcCtD
Prazosin—Asthenia—Hydroxyurea—head and neck cancer	0.000229	0.0101	CcSEcCtD
Prazosin—SLC22A3—lymph node—head and neck cancer	0.000228	0.00799	CbGeAlD
Prazosin—Tachycardia—Fluorouracil—head and neck cancer	0.000224	0.00986	CcSEcCtD
Prazosin—ADRA2A—thyroid gland—head and neck cancer	0.000222	0.00779	CbGeAlD
Prazosin—Vomiting—Vinblastine—head and neck cancer	0.000222	0.00979	CcSEcCtD
Prazosin—Headache—Vinblastine—head and neck cancer	0.000219	0.00965	CcSEcCtD
Prazosin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000218	0.00961	CcSEcCtD
Prazosin—Flushing—Docetaxel—head and neck cancer	0.000216	0.00953	CcSEcCtD
Prazosin—CYP1A1—head—head and neck cancer	0.000212	0.00741	CbGeAlD
Prazosin—Dizziness—Hydroxyurea—head and neck cancer	0.000211	0.00928	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000209	0.00921	CcSEcCtD
Prazosin—Nausea—Vinblastine—head and neck cancer	0.000208	0.00914	CcSEcCtD
Prazosin—Insomnia—Fluorouracil—head and neck cancer	0.000207	0.00914	CcSEcCtD
Prazosin—Paraesthesia—Fluorouracil—head and neck cancer	0.000206	0.00907	CcSEcCtD
Prazosin—Alopecia—Docetaxel—head and neck cancer	0.000206	0.00907	CcSEcCtD
Prazosin—Dyspnoea—Fluorouracil—head and neck cancer	0.000204	0.00901	CcSEcCtD
Prazosin—Somnolence—Fluorouracil—head and neck cancer	0.000204	0.00898	CcSEcCtD
Prazosin—Vomiting—Hydroxyurea—head and neck cancer	0.000203	0.00893	CcSEcCtD
Prazosin—Rash—Hydroxyurea—head and neck cancer	0.000201	0.00885	CcSEcCtD
Prazosin—Dermatitis—Hydroxyurea—head and neck cancer	0.000201	0.00884	CcSEcCtD
Prazosin—Headache—Hydroxyurea—head and neck cancer	0.0002	0.0088	CcSEcCtD
Prazosin—ADRA2A—head—head and neck cancer	0.000197	0.00691	CbGeAlD
Prazosin—Pain—Fluorouracil—head and neck cancer	0.000196	0.00864	CcSEcCtD
Prazosin—Nausea—Hydroxyurea—head and neck cancer	0.000189	0.00834	CcSEcCtD
Prazosin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000189	0.00833	CcSEcCtD
Prazosin—Urticaria—Fluorouracil—head and neck cancer	0.000182	0.00803	CcSEcCtD
Prazosin—Syncope—Docetaxel—head and neck cancer	0.000182	0.00802	CcSEcCtD
Prazosin—Body temperature increased—Fluorouracil—head and neck cancer	0.000181	0.00799	CcSEcCtD
Prazosin—Palpitations—Docetaxel—head and neck cancer	0.000179	0.0079	CcSEcCtD
Prazosin—Loss of consciousness—Docetaxel—head and neck cancer	0.000178	0.00786	CcSEcCtD
Prazosin—ABCB1—epithelium—head and neck cancer	0.000177	0.0062	CbGeAlD
Prazosin—KCNH2—lymph node—head and neck cancer	0.000175	0.00615	CbGeAlD
Prazosin—Arthralgia—Docetaxel—head and neck cancer	0.000173	0.00761	CcSEcCtD
Prazosin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000169	0.00745	CcSEcCtD
Prazosin—Dry mouth—Docetaxel—head and neck cancer	0.000169	0.00744	CcSEcCtD
Prazosin—Oedema—Docetaxel—head and neck cancer	0.000166	0.00729	CcSEcCtD
Prazosin—Shock—Docetaxel—head and neck cancer	0.000163	0.00718	CcSEcCtD
Prazosin—Pruritus—Fluorouracil—head and neck cancer	0.000162	0.00715	CcSEcCtD
Prazosin—Tachycardia—Docetaxel—head and neck cancer	0.000162	0.00712	CcSEcCtD
Prazosin—Diarrhoea—Fluorouracil—head and neck cancer	0.000157	0.00691	CcSEcCtD
Prazosin—ABCB1—trachea—head and neck cancer	0.000157	0.00549	CbGeAlD
Prazosin—ABCG2—lymph node—head and neck cancer	0.000156	0.00547	CbGeAlD
Prazosin—Dizziness—Fluorouracil—head and neck cancer	0.000152	0.00668	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000151	0.00665	CcSEcCtD
Prazosin—Insomnia—Docetaxel—head and neck cancer	0.00015	0.0066	CcSEcCtD
Prazosin—Paraesthesia—Docetaxel—head and neck cancer	0.000149	0.00655	CcSEcCtD
Prazosin—CYP1A1—lymph node—head and neck cancer	0.000148	0.00519	CbGeAlD
Prazosin—Dyspnoea—Docetaxel—head and neck cancer	0.000148	0.0065	CcSEcCtD
Prazosin—Somnolence—Docetaxel—head and neck cancer	0.000147	0.00648	CcSEcCtD
Prazosin—Vomiting—Fluorouracil—head and neck cancer	0.000146	0.00643	CcSEcCtD
Prazosin—Rash—Fluorouracil—head and neck cancer	0.000145	0.00637	CcSEcCtD
Prazosin—Dermatitis—Fluorouracil—head and neck cancer	0.000144	0.00637	CcSEcCtD
Prazosin—Headache—Fluorouracil—head and neck cancer	0.000144	0.00633	CcSEcCtD
Prazosin—Fatigue—Docetaxel—head and neck cancer	0.000143	0.00629	CcSEcCtD
Prazosin—Pain—Docetaxel—head and neck cancer	0.000142	0.00624	CcSEcCtD
Prazosin—Constipation—Docetaxel—head and neck cancer	0.000142	0.00624	CcSEcCtD
Prazosin—ADRA2A—lymph node—head and neck cancer	0.000138	0.00484	CbGeAlD
Prazosin—ABCB1—lymphoid tissue—head and neck cancer	0.000136	0.00478	CbGeAlD
Prazosin—Feeling abnormal—Docetaxel—head and neck cancer	0.000136	0.00601	CcSEcCtD
Prazosin—Nausea—Fluorouracil—head and neck cancer	0.000136	0.006	CcSEcCtD
Prazosin—Body temperature increased—Docetaxel—head and neck cancer	0.000131	0.00577	CcSEcCtD
Prazosin—ABCB1—thyroid gland—head and neck cancer	0.000124	0.00434	CbGeAlD
Prazosin—Hypersensitivity—Docetaxel—head and neck cancer	0.000122	0.00537	CcSEcCtD
Prazosin—Asthenia—Docetaxel—head and neck cancer	0.000119	0.00523	CcSEcCtD
Prazosin—Pruritus—Docetaxel—head and neck cancer	0.000117	0.00516	CcSEcCtD
Prazosin—Diarrhoea—Docetaxel—head and neck cancer	0.000113	0.00499	CcSEcCtD
Prazosin—ABCB1—head—head and neck cancer	0.00011	0.00385	CbGeAlD
Prazosin—Dizziness—Docetaxel—head and neck cancer	0.000109	0.00482	CcSEcCtD
Prazosin—Vomiting—Docetaxel—head and neck cancer	0.000105	0.00464	CcSEcCtD
Prazosin—Rash—Docetaxel—head and neck cancer	0.000104	0.0046	CcSEcCtD
Prazosin—Dermatitis—Docetaxel—head and neck cancer	0.000104	0.00459	CcSEcCtD
Prazosin—Headache—Docetaxel—head and neck cancer	0.000104	0.00457	CcSEcCtD
Prazosin—Nausea—Docetaxel—head and neck cancer	9.83e-05	0.00433	CcSEcCtD
Prazosin—ABCB1—lymph node—head and neck cancer	7.7e-05	0.0027	CbGeAlD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.33e-05	0.00065	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.32e-05	0.000647	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GRP—head and neck cancer	1.31e-05	0.000643	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—HRAS—head and neck cancer	1.29e-05	0.000632	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT6—head and neck cancer	1.27e-05	0.000624	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.25e-05	0.000612	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—DPYD—head and neck cancer	1.23e-05	0.000602	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—YAP1—head and neck cancer	1.21e-05	0.000594	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—HRAS—head and neck cancer	1.2e-05	0.000589	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.19e-05	0.000582	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.19e-05	0.000582	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—YAP1—head and neck cancer	1.17e-05	0.000572	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—head and neck cancer	1.15e-05	0.000566	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—YAP1—head and neck cancer	1.13e-05	0.000552	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NAT2—head and neck cancer	1.12e-05	0.000549	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—head and neck cancer	1.11e-05	0.000544	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—MAPK3—head and neck cancer	1.09e-05	0.000535	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.08e-05	0.000531	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—MAPK1—head and neck cancer	1.04e-05	0.000509	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—TYMS—head and neck cancer	1.03e-05	0.000507	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.03e-05	0.000505	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—head and neck cancer	1.03e-05	0.000505	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—TYMS—head and neck cancer	1.02e-05	0.000502	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSTM1—head and neck cancer	1.02e-05	0.000501	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.01e-05	0.000496	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—head and neck cancer	1.01e-05	0.000494	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.97e-06	0.000489	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—DPYD—head and neck cancer	9.81e-06	0.000481	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GPX1—head and neck cancer	9.79e-06	0.00048	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP1A1—head and neck cancer	9.69e-06	0.000475	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GPX1—head and neck cancer	9.69e-06	0.000475	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP1A1—head and neck cancer	9.59e-06	0.00047	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—TYMS—head and neck cancer	9.54e-06	0.000468	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—head and neck cancer	9.5e-06	0.000466	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTM1—head and neck cancer	9.43e-06	0.000462	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—YAP1—head and neck cancer	9.31e-06	0.000457	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTGS2—head and neck cancer	9.09e-06	0.000446	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GPX1—head and neck cancer	9.03e-06	0.000443	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—PIK3CA—head and neck cancer	9.01e-06	0.000442	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP1A1—head and neck cancer	8.94e-06	0.000438	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.76e-06	0.00043	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—head and neck cancer	8.75e-06	0.000429	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—head and neck cancer	8.72e-06	0.000427	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NOTCH1—head and neck cancer	8.65e-06	0.000424	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—head and neck cancer	8.63e-06	0.000423	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—head and neck cancer	8.58e-06	0.000421	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.42e-06	0.000413	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—head and neck cancer	8.34e-06	0.000409	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	8.28e-06	0.000406	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—MAPK3—head and neck cancer	8.28e-06	0.000406	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—MAPK3—head and neck cancer	8.11e-06	0.000398	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—TYMS—head and neck cancer	8.08e-06	0.000396	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTM1—head and neck cancer	7.99e-06	0.000392	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTEN—head and neck cancer	7.93e-06	0.000389	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—head and neck cancer	7.89e-06	0.000387	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—MAPK1—head and neck cancer	7.88e-06	0.000386	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—head and neck cancer	7.79e-06	0.000382	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—MAPK1—head and neck cancer	7.71e-06	0.000378	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—head and neck cancer	7.71e-06	0.000378	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GPX1—head and neck cancer	7.65e-06	0.000375	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.64e-06	0.000375	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP1A1—head and neck cancer	7.58e-06	0.000372	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—head and neck cancer	7.52e-06	0.000369	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOTCH1—head and neck cancer	7.41e-06	0.000363	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—PIK3CA—head and neck cancer	7.37e-06	0.000361	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—AKT1—head and neck cancer	7.36e-06	0.000361	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	7.16e-06	0.000351	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	7.01e-06	0.000344	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—TYMS—head and neck cancer	7e-06	0.000343	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—MAPK3—head and neck cancer	6.94e-06	0.00034	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTM1—head and neck cancer	6.92e-06	0.000339	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	6.84e-06	0.000335	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PIK3CA—head and neck cancer	6.69e-06	0.000328	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOTCH1—head and neck cancer	6.69e-06	0.000328	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GPX1—head and neck cancer	6.63e-06	0.000325	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—head and neck cancer	6.61e-06	0.000324	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—MAPK1—head and neck cancer	6.6e-06	0.000324	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—head and neck cancer	6.6e-06	0.000324	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	6.51e-06	0.000319	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	6.46e-06	0.000317	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	6.36e-06	0.000312	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—head and neck cancer	6.32e-06	0.00031	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—PIK3CA—head and neck cancer	6.31e-06	0.000309	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—MAPK3—head and neck cancer	6.26e-06	0.000307	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—head and neck cancer	6.19e-06	0.000304	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	6.15e-06	0.000302	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	6.05e-06	0.000297	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—head and neck cancer	6.02e-06	0.000295	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	5.96e-06	0.000292	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	5.96e-06	0.000292	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—head and neck cancer	5.96e-06	0.000292	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	5.91e-06	0.00029	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—head and neck cancer	5.81e-06	0.000285	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—head and neck cancer	5.76e-06	0.000283	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	5.76e-06	0.000282	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	5.75e-06	0.000282	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	5.75e-06	0.000282	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PIK3CA—head and neck cancer	5.73e-06	0.000281	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—head and neck cancer	5.7e-06	0.00028	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	5.69e-06	0.000279	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTEN—head and neck cancer	5.6e-06	0.000275	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PIK3CA—head and neck cancer	5.59e-06	0.000274	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TYMS—head and neck cancer	5.59e-06	0.000274	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—head and neck cancer	5.58e-06	0.000274	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTM1—head and neck cancer	5.53e-06	0.000271	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.5e-06	0.00027	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	5.48e-06	0.000269	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	5.48e-06	0.000269	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	5.47e-06	0.000268	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	5.46e-06	0.000268	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.39e-06	0.000264	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—head and neck cancer	5.32e-06	0.000261	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	5.3e-06	0.00026	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GPX1—head and neck cancer	5.29e-06	0.00026	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.24e-06	0.000257	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	5.23e-06	0.000257	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	5.17e-06	0.000254	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	5.15e-06	0.000253	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	5.11e-06	0.000251	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—head and neck cancer	5.1e-06	0.00025	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	5.07e-06	0.000249	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	5.06e-06	0.000248	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTEN—head and neck cancer	5.03e-06	0.000246	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—head and neck cancer	5.01e-06	0.000246	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	4.99e-06	0.000245	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTEN—head and neck cancer	4.97e-06	0.000244	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	4.97e-06	0.000244	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	4.87e-06	0.000239	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	4.87e-06	0.000239	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	4.8e-06	0.000235	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	4.79e-06	0.000235	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	4.78e-06	0.000235	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	4.75e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	4.75e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	4.68e-06	0.000229	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	4.65e-06	0.000228	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.65e-06	0.000228	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTEN—head and neck cancer	4.64e-06	0.000227	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	4.62e-06	0.000226	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—head and neck cancer	4.6e-06	0.000226	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—head and neck cancer	4.57e-06	0.000224	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	4.56e-06	0.000223	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—head and neck cancer	4.55e-06	0.000223	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	4.52e-06	0.000222	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	4.52e-06	0.000222	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—head and neck cancer	4.51e-06	0.000221	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	4.49e-06	0.00022	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	4.49e-06	0.00022	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—head and neck cancer	4.44e-06	0.000218	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	4.4e-06	0.000216	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	4.33e-06	0.000212	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—head and neck cancer	4.33e-06	0.000212	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	4.33e-06	0.000212	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.32e-06	0.000212	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	4.29e-06	0.00021	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	4.28e-06	0.00021	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—head and neck cancer	4.23e-06	0.000207	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	4.22e-06	0.000207	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	4.22e-06	0.000207	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTEN—head and neck cancer	4.18e-06	0.000205	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	4.12e-06	0.000202	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	4.1e-06	0.000201	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	4.08e-06	0.0002	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	3.98e-06	0.000195	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	3.95e-06	0.000194	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTEN—head and neck cancer	3.93e-06	0.000193	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	3.92e-06	0.000192	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	3.91e-06	0.000192	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	3.91e-06	0.000192	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—head and neck cancer	3.9e-06	0.000191	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	3.9e-06	0.000191	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	3.9e-06	0.000191	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	3.88e-06	0.00019	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	3.87e-06	0.00019	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—head and neck cancer	3.82e-06	0.000188	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	3.8e-06	0.000186	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	3.78e-06	0.000185	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—head and neck cancer	3.76e-06	0.000184	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—head and neck cancer	3.74e-06	0.000183	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	3.7e-06	0.000181	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	3.66e-06	0.00018	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—head and neck cancer	3.66e-06	0.000179	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	3.63e-06	0.000178	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	3.6e-06	0.000176	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	3.57e-06	0.000175	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	3.56e-06	0.000175	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3CA—head and neck cancer	3.54e-06	0.000174	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	3.54e-06	0.000173	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	3.53e-06	0.000173	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	3.52e-06	0.000173	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	3.52e-06	0.000173	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3CA—head and neck cancer	3.51e-06	0.000172	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—head and neck cancer	3.49e-06	0.000171	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	3.45e-06	0.000169	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	3.4e-06	0.000167	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTEN—head and neck cancer	3.4e-06	0.000167	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	3.4e-06	0.000167	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	3.4e-06	0.000167	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—head and neck cancer	3.4e-06	0.000167	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	3.38e-06	0.000166	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	3.29e-06	0.000161	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—head and neck cancer	3.27e-06	0.000161	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3CA—head and neck cancer	3.27e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	3.24e-06	0.000159	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	3.24e-06	0.000159	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—head and neck cancer	3.23e-06	0.000158	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	3.2e-06	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	3.19e-06	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	3.16e-06	0.000155	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	3.13e-06	0.000154	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—head and neck cancer	3.12e-06	0.000153	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	3.05e-06	0.00015	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	3.02e-06	0.000148	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	2.97e-06	0.000146	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—head and neck cancer	2.96e-06	0.000145	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	2.95e-06	0.000145	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	2.94e-06	0.000144	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—head and neck cancer	2.9e-06	0.000142	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	2.87e-06	0.000141	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	2.87e-06	0.000141	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—head and neck cancer	2.87e-06	0.000141	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—head and neck cancer	2.85e-06	0.00014	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	2.83e-06	0.000139	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	2.81e-06	0.000138	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	2.81e-06	0.000138	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3CA—head and neck cancer	2.77e-06	0.000136	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	2.76e-06	0.000136	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—head and neck cancer	2.73e-06	0.000134	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTEN—head and neck cancer	2.72e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—head and neck cancer	2.72e-06	0.000133	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—head and neck cancer	2.67e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	2.67e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	2.67e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	2.6e-06	0.000127	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	2.5e-06	0.000122	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	2.49e-06	0.000122	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—head and neck cancer	2.41e-06	0.000118	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—head and neck cancer	2.41e-06	0.000118	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.4e-06	0.000118	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	2.32e-06	0.000114	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	2.31e-06	0.000113	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	2.29e-06	0.000113	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—head and neck cancer	2.26e-06	0.000111	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—head and neck cancer	2.24e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	2.14e-06	0.000105	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	2.04e-06	9.99e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—head and neck cancer	1.96e-06	9.61e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.92e-06	9.4e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	1.89e-06	9.29e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—head and neck cancer	1.57e-06	7.68e-05	CbGpPWpGaD
